Magnetic resonance imaging (MRI) has fundamentally changed the landscape of prostate cancer diagnosis and management. In particular, multi-parametric MRI (mpMRI) techniques have exhibited remarkable strides in both sensitivity and specificity. This article delves into the technologies that make up mpMRI and how they complement traditional methods like biopsies for a more nuanced understanding of prostate cancer.
"Multi-parametric MRI of the prostate has been shown to reduce unnecessary prostate biopsies by 51% and increase the detection of intermediate and high-risk prostate cancers by 18%."
What is a multi-parametric MRI prostate?
To explain multi-parametric MRI in layman's terms, consider it a comprehensive medical "scan" that uses multiple techniques to create an incredibly detailed picture of the prostate. This approach combines morphological (structural) and functional data, offering insights that were not previously possible with conventional MRI alone.
Classifications of mpMRI Techniques
Morphological MRI Techniques
Morphological MRI techniques chiefly rely on T1 and T2 imaging to visualise the structure of the prostate gland. About 70% of prostate cancers are found in the peripheral region and appear as dark areas surrounded by normal, light-coloured tissue[^1^].
Functional NMR Imaging
The mpMRI uses dynamic techniques, such as diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCEI), along with structural analysis to get a fuller picture of the health of the prostate. A study showed that DWI has a sensitivity of 62% and a specificity of 90% in assessing tumour aggressiveness based on the Gleason score[^2^].
Understanding Pi-Rads Score
The results of these various tests are combined into a numerical PI-RADS score, ranging from 1 to 5. A score of 4 or 5 generally indicates a high likelihood of malignancy, recommending further tests like a biopsy for confirmation [^3^].
Complementary Techniques: Transperineal Biopsy
Although MRI technologies have significantly improved, biopsy techniques frequently work together to provide a more thorough diagnosis. A trans-perineal biopsy is one of these methods that works incredibly well for finding cancers in the front part of the prostate, which is hard to get to with other biopsy methods.
MRI Fusion-Guided Prostate Biopsy: A Leap Forward or not?
Perhaps one of the most promising advancements in this field is the advent of MRI fusion-guided prostate biopsy. This method merges mpMRI and real-time transrectal ultrasound (TRUS) images to improve the accuracy of biopsies. This technique led to a 51% reduction in the necessity for biopsies among men with elevated PSA levels [^4^].
Reflection on the impact of MRI prostate on prostate cancer diagnosis
The multi-faceted approach of combining mpMRI with traditional diagnostic methods like biopsies presents a more robust and accurate method for diagnosing prostate cancer. This holistic approach enhances our understanding of the disease and aids in more targeted treatments, significantly improving patient outcomes.
References
[^1^]: Tanimoto, A., Nakashima, J., Kohno, H., Shinmoto, H., & Kuribayashi, S. (2007). Prostate cancer screening: The clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. Journal of Magnetic Resonance Imaging, 25(1), 146-152.
[^2^]: Rosenkrantz, A. B., & Taneja, S. S. (2014). Radiologist, be aware: Ten pitfalls that confound the interpretation of multiparametric prostate MRI. American Journal of Roentgenology, 202(1), 109-120.
[^3^]: PI-RADS v2 Guidelines. (2015). American College of Radiology.
[^4^]: Siddiqui, M. M., Rais-Bahrami, S., Turkbey, B., George, A. K., Rothwax, J., Shakir, N., ... & Parnes, H. L. (2015). Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA, 313(4), 390-397.
.webp)
